CLINICAL_TRIALS ClinicalTrials.gov record update

Double Blind, Placebo Controlled Trial, Evaluating the Role of Nasonex® in the Management of Nasal Obstruction Secondary to Adenoids Hypertrophy in Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00553891
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:47.817810+00:00
Published At: 2022-02-18T00:00:00+00:00
Record Updated At: 2022-02-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Nasal Obstruction", "Adenoids Hypertrophy", "Adenoidectomy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-02-18"
protocolSection.identificationModule.nctId: "NCT00553891"
protocolSection.identificationModule.officialTitle: "Double Blind, Placebo Controlled Trial, Evaluating the Role of Nasonex\u00ae in the Management of Nasal Obstruction Secondary to Adenoids Hypertrophy in Children"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.